(Q34840661)

4 August 2017

1 reference

title

Treatment options for insomnia--pharmacodynamics of zolpidem extended-release to benefit next-day performance (English)

1 reference

4 August 2017

1 reference

Richard K Bogan

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

4 August 2017

published in

Postgraduate Medicine

1 reference

4 August 2017

volume

120

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

161-171

1 reference

Epidemiology of insomnia: what we know and what we still need to learn

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Insomnia causes, consequences, and therapeutics: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Chronic insomnia and performance in a 24-h constant routine study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Fatigue and sleep disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Insomnia and its treatment. Prevalence and correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Prevalence, burden, and treatment of insomnia in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Association of sleep time with diabetes mellitus and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Insomnia and heart disease: a review of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Mortality and population drinking: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Serotonin receptors and their function in sleep, anxiety disorders and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Treating insomnia: Current and investigational pharmacological approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Quazepam and flurazepam: long-term use and extended withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

A comparison of the clinical and psychological effects of diazepam and amylobarbitone in anxious patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Risk factors for injurious falls leading to hospitalization or death in a cohort of 19,500 adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Postural Instability and Consequent Falls and Hip Fractures Associated with Use of Hypnotics in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Sedative-hypnotics and human performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

The sleep switch: hypothalamic control of sleep and wakefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Residual and acute effects of flurazepam and triazolam in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

GABA(A)-receptor subtypes: clinical efficacy and selectivity of benzodiazepine site ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Guidelines for the rational use of benzodiazepines. When and what to use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Benzodiazepine side effects: role of pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Efficacy and tolerability of indiplon in older adults with primary insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Memory effects of benzodiazepines: memory stages and types versus binding-site subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Efficacy and safety of zolpidem extended release in elderly primary insomnia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Residual effects of repeated administration of triazolam and nitrazepam in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1916

21 January 2018

Identifiers

DOI

10.3810/PGM.2008.09.1916

1 reference

4 August 2017

1 reference